Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
1994 2
1997 3
1998 2
1999 6
2000 1
2001 3
2004 2
2005 3
2006 1
2008 4
2010 2
2011 4
2012 3
2013 2
2014 2
2015 1
2016 4
2017 4
2018 2
2019 3
2020 8
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Preoperative Molecular Markers in Thyroid Nodules.
Sahli ZT, Smith PW, Umbricht CB, Zeiger MA. Sahli ZT, et al. Among authors: umbricht cb. Front Endocrinol (Lausanne). 2018 Apr 18;9:179. doi: 10.3389/fendo.2018.00179. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29720964 Free PMC article. Review.
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.
Visvanathan K, Cope L, Fackler MJ, Considine M, Sokoll L, Carey LA, Forero-Torres A, Ingle JN, Lin NU, Nanda R, Storniolo AM, Tulac S, Venkatesan N, Wu NC, Marla S, Campbell S, Bates M, Umbricht CB, Wolff AC, Sukumar S. Visvanathan K, et al. Among authors: umbricht cb. Clin Cancer Res. 2023 Feb 16;29(4):784-790. doi: 10.1158/1078-0432.CCR-22-2128. Clin Cancer Res. 2023. PMID: 36534524 Clinical Trial.
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer.
Fackler MJ, Tulac S, Venkatesan N, Aslam AJ, de Guzman TN, Mercado-Rodriguez C, Cope LM, Downs BM, Vali AH, Ding W, Lehman J, Denbow R, Reynolds J, Buckley ME, Visvanathan K, Umbricht CB, Wolff AC, Stearns V, Bates M, Lai EW, Sukumar S. Fackler MJ, et al. Among authors: umbricht cb. Cancer Res Commun. 2022 Jun;2(6):391-401. doi: 10.1158/2767-9764.crc-22-0133. Epub 2022 Jun 1. Cancer Res Commun. 2022. PMID: 36046124 Free PMC article.
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.
Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB. Fackler MJ, et al. Among authors: umbricht cb. NPJ Breast Cancer. 2020 Jan 31;6:3. doi: 10.1038/s41523-020-0145-3. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32025567 Free PMC article.
68 results